The legal battle over abortion pills escalated to the Supreme Court on Saturday, as two manufacturers of mifepristone filed an emergency request warning a lower court ruling is already causing “immediate confusion and upheaval” across the country.Danco Laboratories is asking the high court to quickly block a 5th U.S. Circuit Court of Appeals decision that blocked mail-order access and reinstated in-person requirements for the drug, arguing the ruling is disrupting access and creating nationwide uncertainty about legality.A second manufacturer, GenBioPro, which produces a generic version of mifepristone, also filed an emergency request Saturday with the Supreme Court raising similar concerns.The ruling directly affects the distribution of mifepristone, Danco’s primary product. Mifepristone is one of two drugs commonly used in medication abortions.The application was directed to Justice Samuel Alito, who handles emergency matters from the 5th Circuit and can either act on his own or refer the request to the full court. The Supreme Court could act at any time.ABORTION PILL MIFEPRISTONE SPARKS NEW PRO-LIFE DEBATE AS SOME DOCTORS STRESS SAFETY CONCERNSIn its filing, Danco warned the appeals court’s order is already creating “chaos” in real-world medical settings.”The panel’s ruling injects immediate confusion and upheaval into highly time-sensitive medical decisions,” the company wrote, adding it is forcing “providers, patients, and pharmacies all to guess at what is allowed and what is not.”The filing raises immediate questions, including what happens to existing abortion pill prescriptions, pharmacy dispensing and access to in-person visits.GenBioPro similarly warned the ruling would disrupt access nationwide, arguing in…
Want more insights? Join Grow With Caliber - our career elevating newsletter and get our take on the future of work delivered weekly.
